Outsourcing

Gregg Brandyberry is senior vice-president of FedBid, and formerly senior advisor for A.T. Kearney Procurement and Analytic Solutions, Gregg.Brandyberry@FedBid.com

Articles

Better strategies and practices in sourcing and procurement can contribute to the bottom line.

Offsetting Budget Cuts

Eric Langer has over 25 years experience in biotechnology and life sciences strategic marketing management, market research, and publishing. He has held senior management and marketing positions at biopharmaceutical supply companies. He has published and authored many books and reports on topics in Biotechnology, Large-scale BioManufacturing, and bioscience commercialization and communication. He teaches at Johns Hopkins University marketing management, biotech marketing, services marketing, and marketing in a regulated environment. In 1989 he co-founded BioPlan Associates, Inc. to provide market analysis, and strategy to biotech and healthcare organizations.

A recent industry survey shows keen interest in improving bioreactors and cell-culture media.

Wanted: Better Upstream Bioprocessing Technologies

Jim Miller is president of PharmSource Information Services, Inc., and publisher of Bio/Pharmaceutical Outsourcing Report.

Lessons from the earthquake in Japan show the vulnerability of the bio/pharma supply chain.

Supply Chain Pain

The complexity of third-party external supply networks requires new ways to manage them.

A Hard Look at Third-Party External Supply Networks

Indian manufacturers are not a near-term threat to Western CMOs, but may be long term.

A First-Hand Look at India's Pharma Services Sector

More crucial biomanufacturing operations are expected to be outsourced.

Changes Underway for Biopharmaceutical Outsourcing

CDMOs and CMOs face weak economic recovery, consolidation, and globalization.

What to Watch for in 2011

Covance's deal with sanofi-aventis demonstrates the power of scale and scope.

Winning Big

Post recession and beyond, which contract service providers will still be standing?

Outsourcing Winners in 2014

Global pharmaceutical companies could have a problem getting rid of redundant facilities.

Outsourcing Outlook